PFE Stock News - Pfizer Inc. Stock | Seeking Alpha

PFE

Pfizer Inc.NYSE

1d

5d

1m

6m

1y

5y

10y

AstraZeneca completes sale of antibiotics business to Pfizer
SA News • Fri, Dec. 23 • 3 Comments
Dividends key to beating market?
Video at CNBC.com • Wed, Dec. 21
FDA accepts Pfizer's marketing application for expanded use of breast cancer drug Ibrance; action date April 2017
SA News • Wed, Dec. 21
Pfizer Case Study: Building Wealth With A Loser Stock
Lynn Costlow • Tue, Dec. 20 • 69 Comments
Pfizer: A High-Yield Pharmaceutical Firm With Compelling Growth Drivers
Timothy McIntosh • Tue, Dec. 20 • 25 Comments
ViiV Healthcare launches late-stage study of cabotegravir for prevention of HIV infection
SA News • Tue, Dec. 20 • 6 Comments
ViiV Healthcare's two-drug HIV regimen non-inferior to three/four-drug regimens in HIV maintenance
SA News • Tue, Dec. 20 • 11 Comments
Eucrisa Thumbs Up Validates Pfizer's Takeover Strategy - Partly
EP Vantage • Mon, Dec. 19 • 1 Comment
Portola nabs $50M in new capital from Pfizer and Bristol-Myers to support AndexXa development; shares up 11%
SA News • Mon, Dec. 19 • 5 Comments
Catalyst Bio nabs manufacturing rights to Factor VIIa for hemophilia; shares ahead 4% premarket
SA News • Mon, Dec. 19 • 1 Comment
Expanded use of Pfizer's meningitis vaccine OK'd in Europe
SA News • Mon, Dec. 19
FDA OKs removal of boxed warning from Chantix label
SA News • Fri, Dec. 16 • 7 Comments
European Ad Comm backs Roche's Alecensa for certain type of lung cancer
SA News • Fri, Dec. 16
Mega stocks' mega potential
Video at CNBC.com • Fri, Dec. 16
FDA OKs Pfizer's topical ointment for atopic dermatitis
SA News • Wed, Dec. 14 • 2 Comments

From other sites

Pfizer Completes Acquisition Of Small Molecule Anti-Infective Business From AstraZeneca

at TheStreet (Fri, 2:05AM)
The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Bank of America, Oracle and Nike

at Zacks.com (Thu, 9:30AM)
Pfizer Ibrance sNDA Accepted by FDA under Priority Review

at Zacks.com (Thu, 8:01AM)
Pfizer (PFE) Nimenrix Vaccine's Label Expanded in the EU

at Zacks.com (Wed, 6:19PM)
Stock Research Reports for Pfizer, Microsft & Bank of America

at Zacks.com (Wed, 5:35PM)
FDA Accepts Supplemental New Drug Application For Pfizer's IBRANCE® (palbociclib) In HR+, HER2- Metastatic Breast Cancer

at TheStreet (Wed, 8:00AM)
BioInvent Announces Cancer Immunotherapy Research Collaboration And License Agreement With Pfizer And Issues New Shares To Pfizer

at TheStreet (Wed, 5:14AM)
Pfizer Should Weather The Impending Storm & Remain The Best Value In Pharma

at TalkMarkets (Mon, 10:28AM)
Pfizer Chantix Label Warning Lifted in U.S.; to Add New Data

at Zacks.com (Mon, 8:26AM)
Pfizer Receives Approval In The European Union For Nimenrix™ (Meningococcal Group A, C, W-135, And Y Conjugate Vaccine) In Infants Six Weeks Of Age And Older

at TheStreet (Mon, 7:00AM)